Fmr LLC Organogenesis Holdings Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Fmr LLC holds 129,396 shares of ORGO stock, worth $376,542. This represents 0.0% of its overall portfolio holdings.

Number of Shares

129,396

Previous 84,652 52.86%

Holding current value

$376,542

Previous $240,000 50.83%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.28 - $3.03 $102,016 - $135,574	44,744 Added 52.86%	129,396 $362,000
Q1 2024 May 13, 2024	SELL	$2.61 - $4.49 $1,297 - $2,231	-497 Reduced 0.58%	84,652 $240,000
Q4 2023 Feb 13, 2024	SELL	$1.97 - $4.21 $2,263 - $4,837	-1,149 Reduced 1.33%	85,149 $348,000
Q3 2023 Nov 13, 2023	SELL	$2.34 - $4.43 $699 - $1,324	-299 Reduced 0.35%	86,298 $274,000
Q2 2023 Aug 11, 2023	BUY	$1.9 - $4.3 $158,701 - $359,166	83,527 Added 2720.75%	86,597 $287,000
Q1 2023 May 11, 2023	BUY	$1.89 - $2.93 $2,621 - $4,063	1,387 Added 82.41%	3,070 $6,000
Q4 2022 Feb 13, 2023	SELL	$2.48 - $3.43 $2,539 - $3,512	-1,024 Reduced 37.83%	1,683 $4,000
Q3 2022 Nov 10, 2022	SELL	$3.14 - $6.43 $1,818 - $3,722	-579 Reduced 17.62%	2,707 $9,000
Q2 2022 Aug 12, 2022	SELL	$4.74 - $8.15 $42,370 - $72,852	-8,939 Reduced 73.12%	3,286 $16,000
Q1 2022 May 13, 2022	SELL	$6.47 - $9.57 $5.14 Million - $7.6 Million	-794,175 Reduced 98.48%	12,225 $93,000
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $391,468 - $585,900	43,400 Added 5.69%	806,400 $7.45 Million
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $10.5 Million - $13.1 Million	763,000 New	763,000 $10.9 Million

Others Institutions Holding ORGO

# of Institutions

120

Shares Held

62.3M

Call Options Held

28.8K

Put Options Held

27.9K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $381M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account